Patients on Medication-Assisted Treatments for Opioid Use Disorder (Baltimore)

The Johns Hopkins School of Medicine is seeking volunteers for a research study, who are currently enrolled in a treatment program for opioid use disorder (OUD) and are prescribed Methadone, Vivitrol, or Buprenorphine.
This research study is evaluating if a sleep medication, Belsomra (suvorexant), is effective in improving sleep and stress during OUD recovery.
You may be eligible if you: - are currently enrolled in a treatment program for opioid use disorder (OUD) - are prescribed Methadone, Vivitrol, or Buprenorphine - are between the ages of 21-65 - have difficulty sleeping - are NOT pregnant or breastfeeding Participation requires 2 screen visits that last about 4 hours, and 9 weekly visits that last about 30 minutes.
Compensation up to $1000 and free transportation to the Bayview Medical Center will be provided.
If you are interested, please complete the following 3-minute screening survey online: https://jhmi.
co1.
qualtrics.
com/jfe/form/SV_cMGqnmhJWbyopE2 You can also call us at (443) 681-9026 or email 2001morexin@jhu.
edu for more information.
PI: Andrew S.
Huhn, Ph.
D.
Protocol: IRB00223942.